These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 4732209)
1. [Observations on drug quality and the QUAD program]. Lalonde M Vie Med Can Fr; 1973 May; 2(5):497-502. PubMed ID: 4732209 [No Abstract] [Full Text] [Related]
2. QUAD routes out inferior drugs. Can Hosp; 1973 May; 50(5):58-9. PubMed ID: 4779804 [No Abstract] [Full Text] [Related]
3. Drug product quality. Exp Med Surg; 1971; 29(1):135-44. PubMed ID: 5147595 [No Abstract] [Full Text] [Related]
4. Quality control of pharmaceutical preparations and the Third World. Summers RS Cent Afr J Med; 1983 Dec; 29(12):247-9. PubMed ID: 6671214 [No Abstract] [Full Text] [Related]
5. 3. Drug regulations in Switzerland and their application. Hippenmeier F Bull Parenter Drug Assoc; 1974; 28(4):167-73. PubMed ID: 4855448 [No Abstract] [Full Text] [Related]
6. Quality assurance of drugs--the QUAD program. Leclerc-Chevalier D Drug Inf J; 1978; 12(1):23-5. PubMed ID: 10316626 [No Abstract] [Full Text] [Related]
7. Quality control and testing of drugs in Canada. WARMINTON RG Appl Ther; 1963 May; 5():448-53. PubMed ID: 13998944 [No Abstract] [Full Text] [Related]
8. [Various aspects of the significance of government control in drug supply]. Teijgeler CA; Samsom RJ Pharm Weekbl; 1969 Jun; 104(26):539-49. PubMed ID: 5788999 [No Abstract] [Full Text] [Related]
9. Where does drug importation stand now? Guglielmo WJ Med Econ; 2005 Mar; 82(6):42, 44, 46. PubMed ID: 15869085 [No Abstract] [Full Text] [Related]
11. WHO Expert Committee on Specifications for Pharmaceutical Preparations. World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913 [TBL] [Abstract][Full Text] [Related]
12. Seizures of Canadian drugs rise as Congress, Customs spar. Carreyrou J Wall St J (East Ed); 2006 Jul; ():B1, B8. PubMed ID: 16909501 [No Abstract] [Full Text] [Related]
13. [Guidelines for introducing new drugs for medical use in Poland and control of their quality]. Danysz A Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321 [No Abstract] [Full Text] [Related]
14. The relationship between the pharmaceutical industry and government agencies. Johnston RV J Am Vet Med Assoc; 1965 Dec; 147(12):1588-92. PubMed ID: 5884057 [No Abstract] [Full Text] [Related]
15. Development of quality control methodology for new drugs. Wagner RL Bull Parenter Drug Assoc; 1972; 26(2):76-86. PubMed ID: 5012206 [No Abstract] [Full Text] [Related]
16. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality? Marsh DA; Hoar ME Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245 [TBL] [Abstract][Full Text] [Related]
17. Securing the US pharmaceutical supply. Somberg JC Am J Ther; 2008; 15(3):197. PubMed ID: 18496255 [No Abstract] [Full Text] [Related]
18. [How to assure the quality of a medicinal product ]. Agosti ME Medicina (B Aires); 2003; 63(5):450-2. PubMed ID: 14628657 [No Abstract] [Full Text] [Related]
19. Responses to the Gagnon report and REBs. Gagnon D; NCBHR Commun; 1993; 4(2):3-5. PubMed ID: 11652886 [No Abstract] [Full Text] [Related]
20. Preliminary observations on the Quality Assurance Service Therapeutic Drug Monitoring Program. Lohff MR Am J Clin Pathol; 1980 Oct; 74(4 Suppl):542-5. PubMed ID: 7435445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]